Key Messages
- Causes of QTc prolongation may be either inherited or acquired
- Drug induced QTc prolongation is the most common aetiology of acquired QTc prolongation
- Risk factors for QTc prolongation may be modifiable or non-modifiable
- Ensure that risk factors are reviewed and any modifiable risk factors such as electrolyte disturbance are corrected
- The concurrent use of more than one drug which prolongs the QTc interval increases the risk of Torsades de Pointes (TdP) and ventricular arrhythmia
- Some drugs which do not prolong the QTc interval themselves can increase the risk of QTc prolongation by affecting the metabolism of drugs which do
- Some drugs can increase the risk of QTc prolongation by causing electrolyte disturbances (in particular hypokalaemia, hypomagnesaemia and more rarely hypocalaemia) especially when given with QTc prolonging drugs
- Prescribers should ensure that the potential benefits of prescribing a QTc prolonging medication outweigh the associated risks, and that when a QTc prolonging medication is prescribed, appropriate mitigations and monitoring are in place
To access the full blog via Microsoft Sway, click here